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for the friends and colleagues of the Department of Medicine at Jefferson Medical College

Project CARE Is Impetus for
Improvement at Jefferson
A significant undertaking of the
Department of Medicine this year is
Project CARE (Coordinated Approaches
Redesigned for Excellence). Spearheaded
by Geno Merli, MD, and Howard Weitz,
MD, and supported by a multidisciplinary
steering committee, the initiative seeks
to improve the standards of care by integrating the latest clinical guidelines into
everyday patient care. The project also
aims to improve efficiency by facilitating
hospital admissions, assessing outcomes,
and streamlining patient services. Two
key diagnoses, Congestive Heart Failure
(CHF) and Acute Coronary Syndromes
(ACS), are the initial focus of the project.

Project CARE steering committee (back
row, left to right): Geno Merli MD, Alan
Forstater MD, 2004 CMR Christopher
DiMaio MD, The Bard Group’s Andrew
Epstein MD, 2003 CMR Steven Mathai
MD, Rachel Sorokin MD, Marion Warchol,
Daniel Louis, and Egle Mangum; (seated,
left to right) Alan Brechbill, Arthur Feldman
MD, PhD, Rebecca O’Shea, and Matthew
DeCaro MD. Not shown: Howard Weitz
MD and Mary Anne McGinley PhD, RN.

The leadership body of the project is
the steering committee (SC), which takes
recommendations and makes decisions
pertaining to accountability and
allocation of resources. Members include
representatives of Jefferson’s many
constituencies—full-time faculty, volunteer

faculty, nursing, house staff, hospital
pharmacy, case management, etc. The
SC has met every four to six weeks since
November, and is supported by the
expertise of The Bard Group, a medical
consulting firm based in Boston. New
task forces were commissioned to explore
bed allocation and utilization and creating
a more effective program for teaching
and clinical care in the CCU.
The cornerstone of Project CARE has
been the two clinical work teams (one
devoted to each diagnosis), which have
been developing practice guidelines with
key decision points targeted to improving
effectiveness and efficiency of care.
Their goal is to devise guidelines that
are understandable and usable for the
greatest number of practitioners, while
also accounting for the necessary degree
of variation. Dr. Weitz, who heads the
ACS clinical team, says, “The document
we have produced now allows for significant freedom of choice. It incorporates
perspectives from full-time and volunteer
faculty in family medicine, internal
medicine, emergency medicine, and
cardiology, and is set up as a framework
so that each of these constituencies can
work together as a team.” The implementation phase will involve regular
educational programs as well as bringing
the guidelines in line with the electronic
order-entry system.
“The format of the guidelines can
accommodate revisions and updates as
new data is released,” says Dr. Merli. His
CHF clinical team is examining how a
new ICCU could better operate in light
of the new environment being created
by Project CARE. Dr. Merli acknowledges
that the most challenging aspect of the
process will be putting the new protocols
into practice, because this will require
Continued on page 6

From the

Chairman
This is the inaugural issue of a new
newsletter from the Department of
Medicine. The name “Translations”
represents a fundamental aspect of
our mission: translating information
from the basic science laboratory,
seminal clinical trials, and outcomes
research to improvements in patient
care as well as student and postgraduate education. While the completion
of the human genome project and
technologic advances in highthroughput genotyping, robotics, and
the molecular biology of many human
diseases have resulted in an explosion
of new therapies and devices, it is
often difficult to keep track of these
many advances, much less identify
what novel resources are available at
Jefferson to help in care of the patient.
The three yearly issues of Translations
will inform you about the department’s ongoing research, clinical,
and educational activities, so that
both doctors and patients are able to
take better advantage of the range
of opportunities available at Jefferson.
The cover article discusses Project
CARE, an important and ongoing
activity that spans the tripartite
missions of the department and
Continued on page 6
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Genomics Core Unlocks the Secrets of the Human Genome
Paolo Fortina, MD, PhD, a clinical molecular genetic investigator, joined Thomas
Jefferson University in September 2002
as Chief of the Center for Translational
Medicine’s Diagnostic and Genomics
Core, one of the center’s four central
facilities. Dr. Fortina was previously
Director of the Molecular Diagnostic Unit
at the Children’s Hospital of Philadelphia

Working with Dr. Paolo Fortina
(top center) in the Genomics Core’s
temporary facilities are (clockwise
from top right) Fei Cao, Wendy
McClure, Kathryn Scott, and
Shannon Cowie.

and Associate Professor of Pediatrics at
the University of Pennsylvania School
of Medicine.
Dr. Fortina brings with him relationships
with various biotech companies, who
share his goal of finding more robust,
cost-effective, and reproducible tools
to investigate the human genome. His
research has focused on biochips, or
microarray technology, by which large sets
of single-stranded nucleic acid molecules
are anchored to a solid surface. The
molecules then participate in a biochemical
reaction with complementary DNA or RNA
molecules, which represent the target to
be interrogated. Thousands of reactions
can be performed simultaneously. A scan
results in a genetic profile of the target
molecules. “The relative simplicity and
flexibility have demonstrated that DNA
microarray technology is one of the most
promising analytical techniques,”
explains Dr. Fortina.
Gene-expression profiling offers the
potential to analyze the “molecular
fingerprints” of thousands of genes within
single cells and responses to internal and
external change agents—all from a single
cell or drop of blood. Dr. Fortina foresees
the impact this will have on the future

of medicine: “Soon it will be possible to
customize drug treatments based on a
patient’s genome as well as determine
whether he/she is a carrier for a certain
disease.”
He adds that one of the most important
needs of our institution over the next
several years will be the ability to define
individual genetic profiles by the
characterization of single nucleotide
polymorphisms (SNPs) and to screen for
characterized mutations in our patients
and in at-risk populations. “Mutation
detection provides a rapid and definitive
method for pinpointing many diseases,”
he says.
The Genomics Core is currently capable
of providing gene-expression profiling
as well as genotyping services for all
investigators on the Jefferson campus,
either for clinical/diagnostic purposes
and/or for research-oriented projects.
Presently located in offices in the
Medical Office Building, the Center will
soon relocate to 30,000 square feet of
newly renovated space on the third and
fourth floors of the College Building. For
more information about the Genomics
Core’s research, contact Dr. Fortina at
Paolo.Fortina@jefferson.edu.

Gastroenterology and Heptatology

New Liver Transplant
Team in Place
Jefferson’s liver transplant team is in
place with new leadership in surgery and
GI/Hepatology. Joining Lloyd Ratner, MD,
Director of Jefferson’s Transplantation
Program, is renowned liver surgeon
Ignazio Marino, MD, the new Director of
Liver Transplant and Associate Director of
the Transplantation Division of Jefferson
Medical College. Victor Navarro, MD,
Medical Director of the Liver Transplantation
Program, recently joined Steven Herrine,
MD, Associate Director, and together
they oversee the evaluation and care of
the patient with liver disease during the
pre- and post-transplant phase, including
the use of immuno-suppressants. Another

https://jdc.jefferson.edu/translations/vol1/iss1/1

addition is Yoogoo Kang, MD, a nationally
recognized liver transplant anesthesiologist.
The team is planning the initiation of the
live donor liver transplant program, which
makes it possible for a patient to receive
a partial liver from a healthy person with
a compatible blood type.

Tiny Capsule Makes
“Fantastic Voyage” a
Virtual Reality
New technology has made it possible
to obtain a picture-perfect view of the
gastrointestinal tract with a procedure
that is barely more invasive than

2

swallowing a pill. With capsule endoscopy,
a vitamin-sized capsule produces more
than 50,000 color photographs of the
stomach and small intestine. The patient
wears a battery-operated data recorder.
Eight leads attached to the patient’s
abdomen receive radiowave images from
the capsule, and after eight hours the
physician downloads the photographs to
a computer to diagnose the problem.
Mitchell I. Conn, MD, Clinical Associate
Professor of Medicine (Gastroenterology
and Hepatology), and Anthony Infantolino
MD, Clinical Assistant Professor in the
division, are leading the clinical research
efforts related to this developing
technology. Jefferson’s is the 5th-largest
program of its kind in the country, and
the first in the Delaware Valley.
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Pulmonary

Asthma Education on the Move

Dr. Bonita Falkner’s long-term study
of hypertension and diabetes has
yielded far-reaching results.

Nephrology

Hypertension Study
Spans Two Decades
Through a series of NIH-funded studies,
Bonita Falkner, MD, Professor of Medicine
and Pediatrics, has had the unique
opportunity over the past two decades
to study a group of individuals since
they were adolescents. Now in their
mid- to late 30s, this cohort of African
Americans—representative of a population
that suffers disproportionately high rates
of hypertension and diabetes—has aided
Dr. Falkner in exploring the relationship
between insulin resistance and blood
pressure.

Salvatore Mangione, MD, Associate
Professor of Medicine, first devised the
idea of a traveling asthma education
program in the mid-90s, as a member
of the Philadelphia Asthma Task Force.
An NIH grant supported efforts to do
city-wide screenings and educational
services with schoolchildren and to raise
awareness about asthma—the numberone cause of children’s hospitalizations,
prescribed therapy, absenteeism, and poor
academic performance. “The problem is
especially pronounced in poor and underserved inner-city communities, where
many children remain undiagnosed,”
explains Dr. Mangione, “and yet it is a
disease that is fully treatable.”
In 1998 he came up with the idea of
using a bus with educational programs
and exhibits that would travel from
school to school. When he learned that
Glaxo Wellcome would fund the program,
a representative suggested that he buy a
double-decker bus. “I thought it was a
joke!” Dr. Mangione says. But once the
funding came through, he found himself
traveling to London to do just that.
Dr. Mangione says the staff at Jefferson
transformed what was a good idea into
a very effective reality. The Department
of Marketing and University Graphics
devised a set of innovative ideas for kids
focusing on recognition and treatment
of the disease and created the design for
the bus.

Since its launch in 2000, the bus has
visited 73 schools and close to 8,000
middle-school students. A 45-minute
program is led by a respiratory educator
on the upper level of the bus, while on
the lower deck students self-administer
a 7-minute videosurvey connected to
ISAAC (the International Study of Asthma
and Allergies in Children) that identifies
five symptoms. The results are in turn
reported to students’ families. “As
many as half of school-age asthmatics in
Philadelphia may be unaware of having
the disease,” says Dr. Mangione.
Educators also introduce the school
group to a series of cartoon characters
developed just for this project: the
Asthma BUS-ters. Students get to take
home a 24-page comic book and trading cards with asthma health tips. The
program was awarded the 2001
President’s award by the American
College of Chest Physicians (ACCP) for
outstanding community service.
GlaxoSmithKline (formerly Glaxo
Wellcome) continues to fund nearly half
of the program’s expenses, and the rest
is covered by a grant from the Centers
for Disease Control (C.D.C.), through
the School District of Philadelphia. Dr.
Mangione and his associates in the Division
of Pulmonary Medicine are in the
process of writing up the data they have
compiled, which he feels has significance
for future treatment of the disease.

Dr. Falkner has been particularly interested
in insulin resistance as a condition that
precedes the onset of Type 2 diabetes.
“We are now looking to see if we can
detect evidence of vessel injury before
the disease is expressed,” she explains.
Another aspect of the study is whether in
premenopausal women a relative excess
of androgens can lead to a greater risk
for diabetes and hypertension.
“It has been a luxury to study this group
over such an extended period of time,”
says Dr. Falkner. “I would not have predicted these types of studies when we
first began in the early ’80s.” She hopes
to continue her research in order to identify the critical stages for injury and more
specific therapeutic targets for protection
within this high-risk ethnic group.
Dr. Sal Mangione’s bus program has
brought asthma education to 8,000
Philadelphia schoolchildren.
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Cardiology/Internal Medicine

Anticoagulation Program Offers Team-Based Care

“The program used to be managed by
physicians, but the current setup offers
a new level of continuity of care with all

patients,” says Dr. diEugenio. “We
provide patient education, try to prevent
adverse events, and offer follow-up,
ensuring that patients get adequate care
once they leave.” This also decreases the
number of hospital admissions and
decreases patients’ length of stay,
“along with making for the best care,”
she adds. Lovenox, for example, is a
drug that offers “bridge therapy,” so
patients can go home and are not stuck
in the hospital on an IV.
Says Dr. Merli, “The new anticoagulation
center will also be the source of information and will facilitate within our
practice the use of cutting-edge drugs
that will be out in the next year or two.”

Endocrinology, Diabetes, Metabolic Diseases

HealthWorks: A Model for Diabetes Education
The Division of Endocrinology has
assumed HealthWorks, the diabetes selfmanagement program formerly offered
by Thomas Jefferson University Hospital
(TJUH) and currently being run in
partnership with the hospital. The first
classes offered by Endocrinology began
in March. The main goal of the program,
according to Barry Goldstein, MD, PhD,
Director of the Division of Endocrinology,
is to educate patients about every aspect
of diabetes management. “Ours is a
comprehensive diabetes education
program, administratively coordinated
with the hospital and a multidisciplinary
advisory board,” says Dr. Goldstein, “which
includes members of the Departments
of Family Medicine, Nursing, Community
Health, and the Division of Internal
Medicine.”
HealthWorks was awarded recognition
by the American Diabetes Association in
accordance with the National Standards
for Diabetes Self-Management Education
Programs. Managing the program with
Dr. Goldstein is Cheryl Marco, RD, CDE,
a registered dietitian and certified diabetes educator. The six-session program
covers pathophysiology of diabetes and
lifestyle issues such as exercise, goal
setting, and diet. It also teaches patients
and family members about medications,
insulin, blood sugar monitoring, and
preventing complications.

https://jdc.jefferson.edu/translations/vol1/iss1/1

“Through the program, the division
provides patient access to an excellent
educational curriculum, which is often
difficult to find in Philadelphia,” explains
Dr. Goldstein. “Within the Endocrine
Division, HealthWorks is just one
component of the varied set of resources
providing high-quality diabetes education
to all patients throughout the Jefferson
community.” In addition to HealthWorks,
Cheryl Marco leads a series of programs
including one-on-one sessions for
individual patients, 90-minute groups
covering diet and medication, and a
3-week series about optimizing insulin
management. According to Ms. Marco,
these additional programs offer “a
valuable alternative for patients who
cannot commit to the full 6-week series.”
Patients can have direct access to these
programs and need not be seen by an
endocrinologist to receive diabetes
education. A simple form is required to
indicate the reasons and goals for the
referral. Forms are available from Ms.
Marco at cheryl.marco@jefferson.edu.
Patients can obtain information about
HealthWorks directly by calling
1-800-JEFF-NOW.

4

Deborah diEugenio, PharmD (far
right), and Geraldine Santoro, RN
(center), run Internal Medicine’s new
team-based anticoagulation program.

Education
Residency Program
and Recruitment
This year the Department of Medicine
received nearly 2,500 applications and
interviewed 420 candidates for just
44 places. The current class of interns
represents 12 states, including
California, Texas, Michigan, Arkansas,
Mississippi, Tennessee, Virginia, Illinois,
and Wisconsin, as well as New England.
“We have been highly successful at
recruiting top students from across the
country,” says Gregory Kane, MD,
Director of the Residency Program.
Dr. Kane and the Department of
Medicine leadership have also been
working to restructure the internal
medicine residency program to meet
the 80-hour workweek mandate. “We
are confident,” says Dr. Kane, “that our
solutions will preserve the continuity of
care and teaching that are a part of the
Jefferson tradition.”

4
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A nurse/pharmacologist-run anticoagulation program has been established
within the Division of General Internal
Medicine. Deborah diEugenio, PharmD,
who trained as a pharmacologist at the
Temple University School of Medicine
and was a resident at Jefferson last year,
works as a part of a team of physicians,
PharmDs, and nurse practitioners
co-directed by Geno Merli, MD, and
Bernardo Menajovsky, MD, and based in
Internal Medicine. The team provides
Jefferson patients with antithrombotics
therapy and services.
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A Critical Juncture
The financial exigencies of the 2000s
have made it increasingly difficult to
support the academic missions of the
Department of Medicine through NIH
grants and professional fee revenues
alone. Philanthropic giving therefore
becomes a critical ingredient in
supporting the future of academic
medicine. Thus, we are pleased to
announce the Department of Medicine’s
new development efforts, which will
enable us to fund innovative and exciting
research and programs such as the
Center for Translational Medicine.
Our new Director of Development is
Susan Schiffrin, MBA, who comes to us

Susan Schiffrin is
the new Director
of Development
for the Department
of Medicine.

with extensive experience with a
range of fund-raising organizations in
Philadelphia, including the American
Society for Technion, the Fiel Foundation,
the Jewish Federation of Greater
Philadelphia, and the University of
Pennsylvania. Ms. Schiffrin also served
as a senior aide to former Senator Bill
Bradley (D-NJ) in Washington, D.C.

the Medical College Building at 1025
Walnut Street, Philadelphia.

Individuals interested in making a gift
to the Department of Medicine, one
of its 13 divisions, or a member of the
faculty should contact Ms. Schiffrin
at 215-955-7556 or via e-mail at
susan.schiffrin@jefferson.edu. Her
office is located on the 8th floor of

The Department wishes to extend our
warmest thanks to the many generous
individuals and corporations who have
supported the Department of Medicine
to date, and look forward to their
continued participation in our future
development initiatives.

Faculty News
DeHoratius Named
ACR President

Pulmonary Fellows Take
Home ACCP Award

Raphael DeHoratius, MD, was named
President of the American College of
Rheumatology (ACR) at this year’s
academic annual research meeting held
in October in New Orleans. A member
of the organization since 1974, Dr.
DeHoratius has been a dedicated and
prolific volunteer in the organization,
with distinguished service on the ACR
board of directors from 1990 to 1994
and 1997 to present. He was also Vice
President of the Research and Education
Foundation from 1996 to 1997 and
Consulting Editor of Clinical Care in
Rheumatic Diseases, 2nd ed. He became
the ACR Vice-President in 2000 and
President Elect in 2001.

Three Jefferson pulmonary/critical care
fellows won the American College of
Chest Physicians (ACCP) CHEST
Challenge held in San Diego at the
ACCP National Meeting in November.
After six months of online qualifying
rounds against challengers from 88
other medical schools, Bharat Asware,
Vikas Batra, and Rodolfo Pascual
emerged victorious in a Jeopardy-style
competition of pulmonary-related
questions, bringing home trophies as
well as $5,000 for research. Dr. Asware
is Clinical Assistant Professor of Medicine
and Director of the Medical Respiratory
Intensive Care Unit. All three completed
their fellowships in June 2002.

Over the years Dr. DeHoratius has been
involved in ACR’s educational efforts.
“There are approximately five thousand
rheumatologists in the United States,
and five full-time at Jefferson,” he says,
“therefore part of the goal of the ACR
is to increase the number of physicians
going into academic rheumatology
divisions.” The ACR’s 2003 Annual
Scientific Meeting and
Basic Research Conference
will take place in Orlando
in October.

Dr. Raphael DeHoratius
is current president of the
American College of
Rheumatology.

Published by Jefferson Digital Commons, 2009

Dr. Neal Flomenberg (right) receives
congratulations from Dr. Gerard
Berry, Vice Dean for Research, JMC,
at the March 27 Gratz Prize ceremony.

Flomenberg Receives
2003 Gratz Prize
In March Neal Flomenberg, MD,
Professor of Medicine and Microbiology/
Immunology and Director of the Division
of Medical Oncology, was awarded the
Jefferson Medical College Simon Gratz
Research Prize. The $20,000 prize is
awarded once every three years to JMC
alumni whose work over the past five
years is deemed to have “most furthered
the advancement of medical or surgical
treatment of disease or…produced
results having real practical value.” The
prize was presented March 27 as part of
Sigma Xi Student Research Day program.
Says Dr. Flomenberg, “I am honored that
my work has been recognized by my
alma mater for its relevance in helping
to affect patients’ lives. It has been a
great privilege to continue to work and
contribute as a faculty member.”
5
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Pulmonary fellows Drs. Pascual,
Asware, and Batra (left to right) bested
fellows from 88 medical schools across
the country in a recent competition.
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Continued from page 1

changing standards that have been in
place for many years. “This is an important step in the process, and yet we are
confident because the project has been
an interdisciplinary effort that involves
staff at all levels of experience,” says Dr.
Merli. “The Steering Committee and
clinical work teams, in combination with
nursing and administration, have begun
to bring about a real change in terms
of what is possible at Jefferson,” he
continues. “This has already had a
significant impact on the hospital as a
whole, in areas of case management, the
ER, and how patients are assigned to the
house staff.”
The next steps in Project CARE are to
finalize the guidelines and plan for their
implementation, which will continue
throughout the fall. Tracking tools will
ultimately be put in place to monitor
the hospital’s activity to ensure that it is
consistent with the guidelines and having
the desired impact. Dr. Weitz is confident
that the work he and his team have
devoted to Acute Coronary Syndromes
will have numerous benefits. He says,

“Our current activity will result in strategic and long-term benefits for the hospital as well as the medical school.”
Research and educational efforts of Project
CARE are supported by educational
grants from Astra Zeneca, LP; Medtronic;
Guidant; Scios, Inc.; and the TJU
Cardiology Research Foundation.

From the Chairman
Continued from page 1

links closely with Thomas Jefferson
University Hospital (TJUH). Perhaps one
of the most important activities carried
out by the department in the recent past,
Project CARE focuses on improving the
quality of care for patients at Jefferson
and enhancing the satisfaction of both
patients and staff. Although focused
initially on Acute Coronary Syndromes
and Heart Failure, we are confident that
Project CARE will play a critical role in
improving care for all common discharge
diagnoses. Led by a multidisciplinary
team, Project CARE will undoubtedly
have a significant impact on the care
of all patients at Jefferson.

Academic medicine faces great challenges,
requiring that we constantly reassess
and re-engineer its goals and missions in
order to survive. We must place ourselves
on the leading edge of research and
clinical care, expeditiously provide care
to an aging population, provide the latest
innovations in clinical research to our
patient population, and develop innovative
means to support the academic missions
of research and teaching. Despite these
challenges, we are excited about the
future of Jefferson Medicine. In the years
ahead we hope that Translations will be
a convenient vehicle to keep the Jefferson
family apprised of new advances at our
institution and to introduce you to new
people who have joined the family.
Working together, we will continue to
strive to maintain the quality of medicine
that has provided care for the people of
Philadelphia and the region since 1824.

Arthur M. Feldman, MD, PhD
Magee Professor of Medicine
and Chairman of the Department
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